nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—HTR2C—Sorafenib—thyroid cancer	0.212	0.3	CbGbCtD
Trimipramine—CYP2C19—Sorafenib—thyroid cancer	0.0837	0.118	CbGbCtD
Trimipramine—CYP2C9—Sorafenib—thyroid cancer	0.0696	0.0982	CbGbCtD
Trimipramine—ABCB1—Sorafenib—thyroid cancer	0.0675	0.0953	CbGbCtD
Trimipramine—CYP3A4—Vandetanib—thyroid cancer	0.0671	0.0948	CbGbCtD
Trimipramine—CYP2D6—Sorafenib—thyroid cancer	0.0636	0.0898	CbGbCtD
Trimipramine—ABCB1—Doxorubicin—thyroid cancer	0.041	0.0578	CbGbCtD
Trimipramine—CYP3A4—Sorafenib—thyroid cancer	0.0405	0.0571	CbGbCtD
Trimipramine—CYP2D6—Doxorubicin—thyroid cancer	0.0386	0.0545	CbGbCtD
Trimipramine—CYP3A4—Doxorubicin—thyroid cancer	0.0246	0.0347	CbGbCtD
Trimipramine—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.00585	0.029	CcSEcCtD
Trimipramine—Gynaecomastia—Sorafenib—thyroid cancer	0.00381	0.0188	CcSEcCtD
Trimipramine—Pollakiuria—Vandetanib—thyroid cancer	0.00366	0.0181	CcSEcCtD
Trimipramine—Stomatitis—Vandetanib—thyroid cancer	0.00344	0.017	CcSEcCtD
Trimipramine—Arrhythmia—Vandetanib—thyroid cancer	0.00283	0.014	CcSEcCtD
Trimipramine—Alopecia—Vandetanib—thyroid cancer	0.0028	0.0139	CcSEcCtD
Trimipramine—Dysgeusia—Vandetanib—thyroid cancer	0.0027	0.0134	CcSEcCtD
Trimipramine—Vision blurred—Vandetanib—thyroid cancer	0.0026	0.0129	CcSEcCtD
Trimipramine—Tremor—Vandetanib—thyroid cancer	0.00258	0.0128	CcSEcCtD
Trimipramine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00246	0.0122	CcSEcCtD
Trimipramine—Convulsion—Vandetanib—thyroid cancer	0.00239	0.0118	CcSEcCtD
Trimipramine—Hypertension—Vandetanib—thyroid cancer	0.00238	0.0118	CcSEcCtD
Trimipramine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00235	0.0116	CcSEcCtD
Trimipramine—Anxiety—Vandetanib—thyroid cancer	0.00234	0.0116	CcSEcCtD
Trimipramine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00233	0.0116	CcSEcCtD
Trimipramine—Myocardial infarction—Sorafenib—thyroid cancer	0.00233	0.0116	CcSEcCtD
Trimipramine—Bone marrow depression—Epirubicin—thyroid cancer	0.00233	0.0115	CcSEcCtD
Trimipramine—Stomatitis—Sorafenib—thyroid cancer	0.00232	0.0115	CcSEcCtD
Trimipramine—Jaundice—Sorafenib—thyroid cancer	0.00232	0.0115	CcSEcCtD
Trimipramine—Dry mouth—Vandetanib—thyroid cancer	0.0023	0.0114	CcSEcCtD
Trimipramine—Oedema—Vandetanib—thyroid cancer	0.00225	0.0111	CcSEcCtD
Trimipramine—Thrombocytopenia—Vandetanib—thyroid cancer	0.0022	0.0109	CcSEcCtD
Trimipramine—Bone marrow depression—Doxorubicin—thyroid cancer	0.00216	0.0107	CcSEcCtD
Trimipramine—Insomnia—Vandetanib—thyroid cancer	0.00204	0.0101	CcSEcCtD
Trimipramine—Paraesthesia—Vandetanib—thyroid cancer	0.00202	0.01	CcSEcCtD
Trimipramine—Tinnitus—Sorafenib—thyroid cancer	0.00199	0.00986	CcSEcCtD
Trimipramine—Flushing—Sorafenib—thyroid cancer	0.00198	0.00982	CcSEcCtD
Trimipramine—Dyspepsia—Vandetanib—thyroid cancer	0.00198	0.00981	CcSEcCtD
Trimipramine—Decreased appetite—Vandetanib—thyroid cancer	0.00196	0.00968	CcSEcCtD
Trimipramine—Fatigue—Vandetanib—thyroid cancer	0.00194	0.0096	CcSEcCtD
Trimipramine—Constipation—Vandetanib—thyroid cancer	0.00193	0.00953	CcSEcCtD
Trimipramine—Petechiae—Epirubicin—thyroid cancer	0.00191	0.00946	CcSEcCtD
Trimipramine—Arrhythmia—Sorafenib—thyroid cancer	0.00191	0.00945	CcSEcCtD
Trimipramine—Alopecia—Sorafenib—thyroid cancer	0.00189	0.00935	CcSEcCtD
Trimipramine—Dysgeusia—Sorafenib—thyroid cancer	0.00182	0.00902	CcSEcCtD
Trimipramine—Abdominal pain—Vandetanib—thyroid cancer	0.00178	0.00881	CcSEcCtD
Trimipramine—Body temperature increased—Vandetanib—thyroid cancer	0.00178	0.00881	CcSEcCtD
Trimipramine—Petechiae—Doxorubicin—thyroid cancer	0.00177	0.00876	CcSEcCtD
Trimipramine—Atrioventricular block—Epirubicin—thyroid cancer	0.00162	0.00803	CcSEcCtD
Trimipramine—Asthenia—Vandetanib—thyroid cancer	0.00162	0.00799	CcSEcCtD
Trimipramine—Hypertension—Sorafenib—thyroid cancer	0.00161	0.00795	CcSEcCtD
Trimipramine—Coordination abnormal—Epirubicin—thyroid cancer	0.0016	0.00793	CcSEcCtD
Trimipramine—Pruritus—Vandetanib—thyroid cancer	0.00159	0.00788	CcSEcCtD
Trimipramine—Dry mouth—Sorafenib—thyroid cancer	0.00155	0.00767	CcSEcCtD
Trimipramine—Diarrhoea—Vandetanib—thyroid cancer	0.00154	0.00762	CcSEcCtD
Trimipramine—Atrioventricular block—Doxorubicin—thyroid cancer	0.0015	0.00743	CcSEcCtD
Trimipramine—Dizziness—Vandetanib—thyroid cancer	0.00149	0.00737	CcSEcCtD
Trimipramine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00149	0.00736	CcSEcCtD
Trimipramine—Coordination abnormal—Doxorubicin—thyroid cancer	0.00148	0.00733	CcSEcCtD
Trimipramine—Anorexia—Sorafenib—thyroid cancer	0.00145	0.00716	CcSEcCtD
Trimipramine—Vomiting—Vandetanib—thyroid cancer	0.00143	0.00708	CcSEcCtD
Trimipramine—Rash—Vandetanib—thyroid cancer	0.00142	0.00702	CcSEcCtD
Trimipramine—Dermatitis—Vandetanib—thyroid cancer	0.00142	0.00702	CcSEcCtD
Trimipramine—Headache—Vandetanib—thyroid cancer	0.00141	0.00698	CcSEcCtD
Trimipramine—Nausea—Vandetanib—thyroid cancer	0.00134	0.00662	CcSEcCtD
Trimipramine—Dyspepsia—Sorafenib—thyroid cancer	0.00134	0.00662	CcSEcCtD
Trimipramine—Decreased appetite—Sorafenib—thyroid cancer	0.00132	0.00653	CcSEcCtD
Trimipramine—Fatigue—Sorafenib—thyroid cancer	0.00131	0.00648	CcSEcCtD
Trimipramine—Constipation—Sorafenib—thyroid cancer	0.0013	0.00643	CcSEcCtD
Trimipramine—Vascular purpura—Epirubicin—thyroid cancer	0.00128	0.00632	CcSEcCtD
Trimipramine—Urticaria—Sorafenib—thyroid cancer	0.00121	0.00597	CcSEcCtD
Trimipramine—Abdominal pain—Sorafenib—thyroid cancer	0.0012	0.00594	CcSEcCtD
Trimipramine—Body temperature increased—Sorafenib—thyroid cancer	0.0012	0.00594	CcSEcCtD
Trimipramine—Purpura—Epirubicin—thyroid cancer	0.00119	0.00586	CcSEcCtD
Trimipramine—Vascular purpura—Doxorubicin—thyroid cancer	0.00118	0.00584	CcSEcCtD
Trimipramine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00117	0.00577	CcSEcCtD
Trimipramine—Purpura—Doxorubicin—thyroid cancer	0.0011	0.00542	CcSEcCtD
Trimipramine—Asthenia—Sorafenib—thyroid cancer	0.00109	0.00539	CcSEcCtD
Trimipramine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00108	0.00534	CcSEcCtD
Trimipramine—Pruritus—Sorafenib—thyroid cancer	0.00107	0.00532	CcSEcCtD
Trimipramine—Ataxia—Epirubicin—thyroid cancer	0.00107	0.00531	CcSEcCtD
Trimipramine—Diarrhoea—Sorafenib—thyroid cancer	0.00104	0.00514	CcSEcCtD
Trimipramine—Dizziness—Sorafenib—thyroid cancer	0.001	0.00497	CcSEcCtD
Trimipramine—Ataxia—Doxorubicin—thyroid cancer	0.000994	0.00492	CcSEcCtD
Trimipramine—Eosinophilia—Epirubicin—thyroid cancer	0.000977	0.00484	CcSEcCtD
Trimipramine—Vomiting—Sorafenib—thyroid cancer	0.000966	0.00478	CcSEcCtD
Trimipramine—Rash—Sorafenib—thyroid cancer	0.000958	0.00474	CcSEcCtD
Trimipramine—Dermatitis—Sorafenib—thyroid cancer	0.000957	0.00473	CcSEcCtD
Trimipramine—Headache—Sorafenib—thyroid cancer	0.000952	0.00471	CcSEcCtD
Trimipramine—Pancytopenia—Epirubicin—thyroid cancer	0.000937	0.00464	CcSEcCtD
Trimipramine—Pollakiuria—Epirubicin—thyroid cancer	0.000912	0.00451	CcSEcCtD
Trimipramine—Eosinophilia—Doxorubicin—thyroid cancer	0.000904	0.00447	CcSEcCtD
Trimipramine—Nausea—Sorafenib—thyroid cancer	0.000902	0.00446	CcSEcCtD
Trimipramine—Weight increased—Epirubicin—thyroid cancer	0.000898	0.00444	CcSEcCtD
Trimipramine—Drowsiness—Epirubicin—thyroid cancer	0.00088	0.00435	CcSEcCtD
Trimipramine—Pancytopenia—Doxorubicin—thyroid cancer	0.000867	0.00429	CcSEcCtD
Trimipramine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000863	0.00427	CcSEcCtD
Trimipramine—Stomatitis—Epirubicin—thyroid cancer	0.000858	0.00424	CcSEcCtD
Trimipramine—Jaundice—Epirubicin—thyroid cancer	0.000858	0.00424	CcSEcCtD
Trimipramine—Pollakiuria—Doxorubicin—thyroid cancer	0.000844	0.00417	CcSEcCtD
Trimipramine—Weight increased—Doxorubicin—thyroid cancer	0.000831	0.00411	CcSEcCtD
Trimipramine—Agranulocytosis—Epirubicin—thyroid cancer	0.000821	0.00406	CcSEcCtD
Trimipramine—Drowsiness—Doxorubicin—thyroid cancer	0.000814	0.00403	CcSEcCtD
Trimipramine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000798	0.00395	CcSEcCtD
Trimipramine—Jaundice—Doxorubicin—thyroid cancer	0.000794	0.00393	CcSEcCtD
Trimipramine—Stomatitis—Doxorubicin—thyroid cancer	0.000794	0.00393	CcSEcCtD
Trimipramine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000786	0.00389	CcSEcCtD
Trimipramine—Agranulocytosis—Doxorubicin—thyroid cancer	0.00076	0.00376	CcSEcCtD
Trimipramine—Tinnitus—Epirubicin—thyroid cancer	0.000737	0.00364	CcSEcCtD
Trimipramine—Flushing—Epirubicin—thyroid cancer	0.000733	0.00363	CcSEcCtD
Trimipramine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000727	0.0036	CcSEcCtD
Trimipramine—Arrhythmia—Epirubicin—thyroid cancer	0.000706	0.00349	CcSEcCtD
Trimipramine—Alopecia—Epirubicin—thyroid cancer	0.000698	0.00345	CcSEcCtD
Trimipramine—Tinnitus—Doxorubicin—thyroid cancer	0.000682	0.00337	CcSEcCtD
Trimipramine—Flushing—Doxorubicin—thyroid cancer	0.000679	0.00336	CcSEcCtD
Trimipramine—Dysgeusia—Epirubicin—thyroid cancer	0.000674	0.00333	CcSEcCtD
Trimipramine—Arrhythmia—Doxorubicin—thyroid cancer	0.000653	0.00323	CcSEcCtD
Trimipramine—Vision blurred—Epirubicin—thyroid cancer	0.000648	0.00321	CcSEcCtD
Trimipramine—Alopecia—Doxorubicin—thyroid cancer	0.000646	0.0032	CcSEcCtD
Trimipramine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000638	0.00316	CcSEcCtD
Trimipramine—Agitation—Epirubicin—thyroid cancer	0.000632	0.00313	CcSEcCtD
Trimipramine—Dysgeusia—Doxorubicin—thyroid cancer	0.000623	0.00308	CcSEcCtD
Trimipramine—Malaise—Epirubicin—thyroid cancer	0.00062	0.00307	CcSEcCtD
Trimipramine—Palpitations—Epirubicin—thyroid cancer	0.000608	0.00301	CcSEcCtD
Trimipramine—Vision blurred—Doxorubicin—thyroid cancer	0.0006	0.00297	CcSEcCtD
Trimipramine—Convulsion—Epirubicin—thyroid cancer	0.000596	0.00295	CcSEcCtD
Trimipramine—Hypertension—Epirubicin—thyroid cancer	0.000594	0.00294	CcSEcCtD
Trimipramine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000591	0.00292	CcSEcCtD
Trimipramine—Agitation—Doxorubicin—thyroid cancer	0.000585	0.00289	CcSEcCtD
Trimipramine—Anxiety—Epirubicin—thyroid cancer	0.000584	0.00289	CcSEcCtD
Trimipramine—Discomfort—Epirubicin—thyroid cancer	0.000579	0.00286	CcSEcCtD
Trimipramine—Malaise—Doxorubicin—thyroid cancer	0.000574	0.00284	CcSEcCtD
Trimipramine—Dry mouth—Epirubicin—thyroid cancer	0.000573	0.00283	CcSEcCtD
Trimipramine—Confusional state—Epirubicin—thyroid cancer	0.000566	0.0028	CcSEcCtD
Trimipramine—Palpitations—Doxorubicin—thyroid cancer	0.000562	0.00278	CcSEcCtD
Trimipramine—Oedema—Epirubicin—thyroid cancer	0.000561	0.00278	CcSEcCtD
Trimipramine—Convulsion—Doxorubicin—thyroid cancer	0.000551	0.00273	CcSEcCtD
Trimipramine—Thrombocytopenia—Epirubicin—thyroid cancer	0.00055	0.00272	CcSEcCtD
Trimipramine—Hypertension—Doxorubicin—thyroid cancer	0.000549	0.00272	CcSEcCtD
Trimipramine—Tachycardia—Epirubicin—thyroid cancer	0.000548	0.00271	CcSEcCtD
Trimipramine—Anxiety—Doxorubicin—thyroid cancer	0.00054	0.00267	CcSEcCtD
Trimipramine—Discomfort—Doxorubicin—thyroid cancer	0.000535	0.00265	CcSEcCtD
Trimipramine—Anorexia—Epirubicin—thyroid cancer	0.000535	0.00265	CcSEcCtD
Trimipramine—Dry mouth—Doxorubicin—thyroid cancer	0.00053	0.00262	CcSEcCtD
Trimipramine—Hypotension—Epirubicin—thyroid cancer	0.000525	0.0026	CcSEcCtD
Trimipramine—Confusional state—Doxorubicin—thyroid cancer	0.000524	0.00259	CcSEcCtD
Trimipramine—Oedema—Doxorubicin—thyroid cancer	0.000519	0.00257	CcSEcCtD
Trimipramine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000509	0.00252	CcSEcCtD
Trimipramine—Insomnia—Epirubicin—thyroid cancer	0.000508	0.00251	CcSEcCtD
Trimipramine—Tachycardia—Doxorubicin—thyroid cancer	0.000507	0.00251	CcSEcCtD
Trimipramine—Paraesthesia—Epirubicin—thyroid cancer	0.000504	0.00249	CcSEcCtD
Trimipramine—Somnolence—Epirubicin—thyroid cancer	0.000499	0.00247	CcSEcCtD
Trimipramine—Anorexia—Doxorubicin—thyroid cancer	0.000495	0.00245	CcSEcCtD
Trimipramine—Dyspepsia—Epirubicin—thyroid cancer	0.000494	0.00244	CcSEcCtD
Trimipramine—Decreased appetite—Epirubicin—thyroid cancer	0.000488	0.00241	CcSEcCtD
Trimipramine—Hypotension—Doxorubicin—thyroid cancer	0.000485	0.0024	CcSEcCtD
Trimipramine—Fatigue—Epirubicin—thyroid cancer	0.000484	0.00239	CcSEcCtD
Trimipramine—Constipation—Epirubicin—thyroid cancer	0.00048	0.00238	CcSEcCtD
Trimipramine—Insomnia—Doxorubicin—thyroid cancer	0.00047	0.00232	CcSEcCtD
Trimipramine—Paraesthesia—Doxorubicin—thyroid cancer	0.000466	0.00231	CcSEcCtD
Trimipramine—Feeling abnormal—Epirubicin—thyroid cancer	0.000463	0.00229	CcSEcCtD
Trimipramine—Somnolence—Doxorubicin—thyroid cancer	0.000462	0.00228	CcSEcCtD
Trimipramine—Dyspepsia—Doxorubicin—thyroid cancer	0.000457	0.00226	CcSEcCtD
Trimipramine—Decreased appetite—Doxorubicin—thyroid cancer	0.000452	0.00223	CcSEcCtD
Trimipramine—Fatigue—Doxorubicin—thyroid cancer	0.000448	0.00222	CcSEcCtD
Trimipramine—Urticaria—Epirubicin—thyroid cancer	0.000446	0.00221	CcSEcCtD
Trimipramine—Constipation—Doxorubicin—thyroid cancer	0.000444	0.0022	CcSEcCtD
Trimipramine—Body temperature increased—Epirubicin—thyroid cancer	0.000444	0.0022	CcSEcCtD
Trimipramine—Abdominal pain—Epirubicin—thyroid cancer	0.000444	0.0022	CcSEcCtD
Trimipramine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000428	0.00212	CcSEcCtD
Trimipramine—Urticaria—Doxorubicin—thyroid cancer	0.000413	0.00204	CcSEcCtD
Trimipramine—Body temperature increased—Doxorubicin—thyroid cancer	0.000411	0.00203	CcSEcCtD
Trimipramine—Abdominal pain—Doxorubicin—thyroid cancer	0.000411	0.00203	CcSEcCtD
Trimipramine—Asthenia—Epirubicin—thyroid cancer	0.000403	0.00199	CcSEcCtD
Trimipramine—Pruritus—Epirubicin—thyroid cancer	0.000397	0.00196	CcSEcCtD
Trimipramine—Diarrhoea—Epirubicin—thyroid cancer	0.000384	0.0019	CcSEcCtD
Trimipramine—Asthenia—Doxorubicin—thyroid cancer	0.000373	0.00184	CcSEcCtD
Trimipramine—Dizziness—Epirubicin—thyroid cancer	0.000371	0.00184	CcSEcCtD
Trimipramine—Pruritus—Doxorubicin—thyroid cancer	0.000367	0.00182	CcSEcCtD
Trimipramine—Vomiting—Epirubicin—thyroid cancer	0.000357	0.00177	CcSEcCtD
Trimipramine—Diarrhoea—Doxorubicin—thyroid cancer	0.000355	0.00176	CcSEcCtD
Trimipramine—Rash—Epirubicin—thyroid cancer	0.000354	0.00175	CcSEcCtD
Trimipramine—Dermatitis—Epirubicin—thyroid cancer	0.000354	0.00175	CcSEcCtD
Trimipramine—Headache—Epirubicin—thyroid cancer	0.000352	0.00174	CcSEcCtD
Trimipramine—Dizziness—Doxorubicin—thyroid cancer	0.000343	0.0017	CcSEcCtD
Trimipramine—Nausea—Epirubicin—thyroid cancer	0.000333	0.00165	CcSEcCtD
Trimipramine—Vomiting—Doxorubicin—thyroid cancer	0.00033	0.00163	CcSEcCtD
Trimipramine—Rash—Doxorubicin—thyroid cancer	0.000327	0.00162	CcSEcCtD
Trimipramine—Dermatitis—Doxorubicin—thyroid cancer	0.000327	0.00162	CcSEcCtD
Trimipramine—Headache—Doxorubicin—thyroid cancer	0.000325	0.00161	CcSEcCtD
Trimipramine—Nausea—Doxorubicin—thyroid cancer	0.000309	0.00153	CcSEcCtD
Trimipramine—HTR2A—Signaling Pathways—PTCH1—thyroid cancer	4.19e-05	0.000469	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTCH1—thyroid cancer	4.18e-05	0.000468	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.17e-05	0.000466	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—NRG1—thyroid cancer	4.16e-05	0.000465	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTCH1—thyroid cancer	4.1e-05	0.000459	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CALCA—thyroid cancer	4.06e-05	0.000455	CbGpPWpGaD
Trimipramine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	4.02e-05	0.00045	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—SLC5A5—thyroid cancer	4.01e-05	0.000449	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CDK1—thyroid cancer	4e-05	0.000448	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—HPGD—thyroid cancer	3.97e-05	0.000445	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SST—thyroid cancer	3.89e-05	0.000435	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CDK1—thyroid cancer	3.86e-05	0.000432	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CDK1—thyroid cancer	3.84e-05	0.00043	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SST—thyroid cancer	3.83e-05	0.000429	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SST—thyroid cancer	3.82e-05	0.000428	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	3.81e-05	0.000426	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—TPR—thyroid cancer	3.79e-05	0.000425	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SST—thyroid cancer	3.75e-05	0.00042	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CALCA—thyroid cancer	3.75e-05	0.000419	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	3.73e-05	0.000418	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TERT—thyroid cancer	3.73e-05	0.000418	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—TPR—thyroid cancer	3.7e-05	0.000415	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.7e-05	0.000414	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CALCA—thyroid cancer	3.69e-05	0.000412	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CALCA—thyroid cancer	3.68e-05	0.000412	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CDK1—thyroid cancer	3.68e-05	0.000412	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	3.64e-05	0.000408	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—KRAS—thyroid cancer	3.64e-05	0.000408	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CALCA—thyroid cancer	3.61e-05	0.000404	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HIF1A—thyroid cancer	3.57e-05	0.000399	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—TPR—thyroid cancer	3.49e-05	0.000391	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SST—thyroid cancer	3.48e-05	0.00039	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—TPR—thyroid cancer	3.46e-05	0.000387	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	3.43e-05	0.000384	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	3.4e-05	0.000381	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CDK1—thyroid cancer	3.39e-05	0.000379	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.38e-05	0.000379	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—RXRA—thyroid cancer	3.37e-05	0.000377	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	3.35e-05	0.000375	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDK1—thyroid cancer	3.34e-05	0.000373	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDK1—thyroid cancer	3.33e-05	0.000373	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	3.27e-05	0.000366	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—TP53—thyroid cancer	3.24e-05	0.000362	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—NRAS—thyroid cancer	3.21e-05	0.000359	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	3.21e-05	0.000359	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—NRAS—thyroid cancer	3.14e-05	0.000352	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.13e-05	0.00035	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NRG1—thyroid cancer	3.1e-05	0.000347	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—HRAS—thyroid cancer	3.1e-05	0.000347	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.09e-05	0.000345	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NRG1—thyroid cancer	3.08e-05	0.000345	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	3.03e-05	0.00034	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—BRAF—thyroid cancer	2.95e-05	0.000331	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	2.95e-05	0.00033	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TERT—thyroid cancer	2.88e-05	0.000323	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.84e-05	0.000318	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TERT—thyroid cancer	2.78e-05	0.000311	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.77e-05	0.00031	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TERT—thyroid cancer	2.77e-05	0.00031	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—KRAS—thyroid cancer	2.76e-05	0.000309	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	2.76e-05	0.000309	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—AKT1—thyroid cancer	2.73e-05	0.000306	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NRG1—thyroid cancer	2.72e-05	0.000305	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	2.71e-05	0.000303	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NRG1—thyroid cancer	2.68e-05	0.0003	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NRG1—thyroid cancer	2.67e-05	0.000299	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.66e-05	0.000298	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	2.66e-05	0.000298	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TERT—thyroid cancer	2.65e-05	0.000297	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	2.65e-05	0.000296	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	2.62e-05	0.000293	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.61e-05	0.000292	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.59e-05	0.00029	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	2.53e-05	0.000284	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TP53—thyroid cancer	2.46e-05	0.000275	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TERT—thyroid cancer	2.44e-05	0.000273	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	2.44e-05	0.000273	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	2.43e-05	0.000272	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.43e-05	0.000272	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TERT—thyroid cancer	2.4e-05	0.000269	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TERT—thyroid cancer	2.4e-05	0.000269	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—RXRA—thyroid cancer	2.39e-05	0.000267	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TERT—thyroid cancer	2.35e-05	0.000263	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—HRAS—thyroid cancer	2.35e-05	0.000263	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	2.34e-05	0.000262	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HIF1A—thyroid cancer	2.34e-05	0.000262	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	2.33e-05	0.000261	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—RXRA—thyroid cancer	2.33e-05	0.000261	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.32e-05	0.00026	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	2.3e-05	0.000257	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	2.3e-05	0.000257	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HIF1A—thyroid cancer	2.29e-05	0.000257	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	2.28e-05	0.000256	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TPR—thyroid cancer	2.28e-05	0.000255	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	2.25e-05	0.000252	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.25e-05	0.000251	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	2.24e-05	0.00025	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	2.23e-05	0.00025	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—BRAF—thyroid cancer	2.2e-05	0.000247	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—RXRA—thyroid cancer	2.2e-05	0.000246	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	2.19e-05	0.000245	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	2.19e-05	0.000245	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—RXRA—thyroid cancer	2.18e-05	0.000244	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CCND1—thyroid cancer	2.16e-05	0.000241	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PPARG—thyroid cancer	2.13e-05	0.000238	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.12e-05	0.000237	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	2.1e-05	0.000235	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	2.09e-05	0.000234	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	2.09e-05	0.000234	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PTEN—thyroid cancer	2.08e-05	0.000233	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—AKT1—thyroid cancer	2.07e-05	0.000232	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	2.06e-05	0.00023	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	2.03e-05	0.000227	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	2.03e-05	0.000227	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—NRAS—thyroid cancer	2.02e-05	0.000226	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	2.02e-05	0.000226	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	2.01e-05	0.000225	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.98e-05	0.000222	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.94e-05	0.000217	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	1.92e-05	0.000215	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.9e-05	0.000213	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.9e-05	0.000213	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.86e-05	0.000209	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—NRAS—thyroid cancer	1.86e-05	0.000208	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.84e-05	0.000206	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	1.78e-05	0.000199	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.77e-05	0.000198	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.74e-05	0.000195	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.74e-05	0.000195	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.73e-05	0.000194	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	1.73e-05	0.000193	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.72e-05	0.000192	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.71e-05	0.000191	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	1.71e-05	0.000191	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.71e-05	0.000191	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.67e-05	0.000187	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.67e-05	0.000187	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	1.67e-05	0.000186	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.66e-05	0.000186	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	1.63e-05	0.000183	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.61e-05	0.00018	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	1.61e-05	0.00018	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.6e-05	0.000179	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—KRAS—thyroid cancer	1.6e-05	0.000179	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	1.59e-05	0.000178	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.59e-05	0.000178	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	1.57e-05	0.000176	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.55e-05	0.000174	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.54e-05	0.000173	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	1.53e-05	0.000171	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.51e-05	0.00017	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.51e-05	0.000169	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.51e-05	0.000169	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.51e-05	0.000169	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.48e-05	0.000166	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.48e-05	0.000166	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	1.48e-05	0.000165	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PPARG—thyroid cancer	1.47e-05	0.000165	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.46e-05	0.000164	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTEN—thyroid cancer	1.46e-05	0.000163	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	1.45e-05	0.000162	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	1.44e-05	0.000161	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.44e-05	0.000161	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.44e-05	0.000161	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—RXRA—thyroid cancer	1.44e-05	0.000161	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	1.43e-05	0.000161	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—thyroid cancer	1.42e-05	0.000159	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.41e-05	0.000158	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	1.41e-05	0.000158	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.39e-05	0.000156	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.39e-05	0.000155	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PPARG—thyroid cancer	1.39e-05	0.000155	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.39e-05	0.000155	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.38e-05	0.000154	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PPARG—thyroid cancer	1.37e-05	0.000154	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.36e-05	0.000153	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	1.36e-05	0.000152	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HRAS—thyroid cancer	1.36e-05	0.000152	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.35e-05	0.000151	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.34e-05	0.00015	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.34e-05	0.00015	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.33e-05	0.000149	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	1.32e-05	0.000148	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	1.31e-05	0.000147	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.31e-05	0.000147	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.31e-05	0.000146	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.31e-05	0.000146	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	1.28e-05	0.000143	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1.26e-05	0.000141	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	1.23e-05	0.000138	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	1.22e-05	0.000137	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.22e-05	0.000136	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKT1—thyroid cancer	1.2e-05	0.000134	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	1.2e-05	0.000134	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NRAS—thyroid cancer	1.19e-05	0.000134	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	1.19e-05	0.000133	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	1.19e-05	0.000133	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.19e-05	0.000133	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000133	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	1.17e-05	0.000131	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—thyroid cancer	1.16e-05	0.00013	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	1.14e-05	0.000127	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—thyroid cancer	1.1e-05	0.000123	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.09e-05	0.000122	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	1.09e-05	0.000122	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.08e-05	0.000121	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—thyroid cancer	1.06e-05	0.000119	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—thyroid cancer	1.05e-05	0.000118	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	1.05e-05	0.000117	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KRAS—thyroid cancer	1.05e-05	0.000117	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTEN—thyroid cancer	1.03e-05	0.000116	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	1.03e-05	0.000115	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KRAS—thyroid cancer	1.03e-05	0.000115	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	1.01e-05	0.000113	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTEN—thyroid cancer	1.01e-05	0.000113	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	1.01e-05	0.000113	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	1.01e-05	0.000113	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	1.01e-05	0.000113	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	9.65e-06	0.000108	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTEN—thyroid cancer	9.51e-06	0.000106	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTEN—thyroid cancer	9.43e-06	0.000106	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	9.37e-06	0.000105	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—thyroid cancer	9.3e-06	0.000104	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	9.27e-06	0.000104	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—thyroid cancer	9.15e-06	0.000102	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—thyroid cancer	9.13e-06	0.000102	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PPARG—thyroid cancer	9.06e-06	0.000101	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	8.96e-06	0.0001	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	8.95e-06	0.0001	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	8.9e-06	9.96e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HRAS—thyroid cancer	8.9e-06	9.96e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	8.75e-06	9.8e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HRAS—thyroid cancer	8.74e-06	9.78e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	8.57e-06	9.59e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	8.52e-06	9.54e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AKT1—thyroid cancer	8.41e-06	9.41e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	8.33e-06	9.32e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	7.96e-06	8.91e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKT1—thyroid cancer	7.86e-06	8.79e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	7.73e-06	8.65e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKT1—thyroid cancer	7.71e-06	8.63e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	7.57e-06	8.47e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—thyroid cancer	7.13e-06	7.98e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	7.03e-06	7.87e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTEN—thyroid cancer	6.22e-06	6.96e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AKT1—thyroid cancer	5.96e-06	6.67e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AKT1—thyroid cancer	5.82e-06	6.51e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AKT1—thyroid cancer	5.48e-06	6.13e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AKT1—thyroid cancer	5.43e-06	6.08e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AKT1—thyroid cancer	3.58e-06	4.01e-05	CbGpPWpGaD
